welcome
Reuters

Reuters

Health

Health

China's health regulator defends quality of local generic drugs

Reuters
Summary
Nutrition label

81% Informative

China 's healthcare regulator defends efficacy of off-patent medicines approved to be distributed through public hospitals.

Investigation into quality concerns had found them to be unsubstantiated, says regulator.

China rolled out bulk-buy programme in 2018 in an attempt to negotiate lower prices from drug manufacturers.